GBM-Multi3D_PI2RL_IINFACTS_2021 - Glioblastoma Next Top Multi 3D Model for Anti-angiogenic Nanomedicines Efficacy Testing. | TOXRUN

Skip to navigation Skip to main content

GBM-Multi3D_PI2RL_IINFACTS_2021 - Glioblastoma Next Top Multi 3D Model for Anti-angiogenic Nanomedicines Efficacy Testing.

Principal Investigator:

Bruno Sarmento

Leader Institution:

CESPU

Research Team:

Bruno Sarmento (PI), Joaquim Monteiro (Co-PI), Ana Baião, Ana Catarina Pacheco, Cláudia Martins, Flávia Castro, Flávia Sousa, Rui Moura

Funding entity:

CESPU

Budget:

9.000€

Period covered:

22.03.2021 - 21.03.2022

Program:

PI2RL_IINFACTS_2021